PatientCareAnywhere Internet-Based Software in Improving Communication and Education in Patients With Cancer and Their Healthcare Providers

Study summary

This partially randomized pilot clinical trial develops and studies a software program, called PatientCareAnywhere, to see whether it can help patients communicate with their doctors and other healthcare providers, and educate themselves about their cancer and treatment options. A program that can help patients learn about their cancer and treatment options, and allows the patient's healthcare providers to receive their questionnaire results, may help patients identify and get help to treat their symptoms.

Ask AI to explain this study

Start here

Key things to know

Main goalSupportive Care

This describes the study’s primary purpose.

What is being studiedCommunication Intervention and Educational Intervention

Plus 3 other study approaches.

Who it may be forBladder Carcinoma · Breast Carcinoma

These are broad labels—not an eligibility decision.

Checked against the public recordLast updated Jun 27, 2024 · Source: ClinicalTrials.gov

Is enrollment open?Completed

Ask the study team to confirm whether enrollment is open.

What kind of study?Not applicable

Interventional

Where is it offered?1 U.S. location

Locations may change over time.

Who runs it?City of Hope Medical Center

Study sponsor

Study overview

What this study is about

Purpose: Supportive Care
Study type: Interventional
Phase: Not applicable
Sponsor: City of Hope Medical Center
Interventions being studied: Other: Communication Intervention; Other: Educational Intervention; Other: Internet-Based Intervention; Other: Quality-of-Life Assessment; Other: Questionnaire Administration

Explore related studies

How this study is categorized

These labels come from structured fields and exact terms in the public record.

Public criteria

Who may be able to participate

The sponsor separates these requirements into two groups. You do not need to interpret them alone—use them to guide a conversation with the study team.

Requirements people may need to meetInclusion criteria

PHASE I AIM 1 (STAKEHOLDER INPUT)
PHASE I AIM 1: Malignant diagnosis in any cancer type at any stage
PHASE I AIM 1: Receiving any type of cancer treatment
PHASE I AIM 1: Life expectancy of at least six months
PHASE I AIM 1: Current outpatient status
PHASE I AIM 1: Fluent in English
PHASE I AIM 1: Internet access at home
PHASE I AIM 3.1 (EVALUATION STUDY)
PHASE I AIM 3.1: Malignant diagnosis in any cancer type at any stage
PHASE I AIM 3.1: Receiving any type of cancer treatment
PHASE I AIM 3.1: Life expectancy of at least six months
PHASE I AIM 3.1: Current outpatient status
PHASE I AIM 3.1: Fluent in English
PHASE I AIM 3.1: Internet access at home
PHASE I AIM 3.2 (PILOT STUDY)
PHASE I AIM 3.2: Malignant diagnosis in breast, gynecologic (GYN), genitourinary (GU) cancer at any stage
PHASE I AIM 3.2: Receiving surgery and/or chemotherapy treatment
PHASE I AIM 3.2: Life expectancy of at least six months
PHASE I AIM 3.2: Current outpatient status (participation will be suspended during hospitalization)
PHASE I AIM 3.2: Fluent in English
PHASE I AIM 3.2: Internet access at home
PHASE II AIM 2 (RANDOMIZED CONTROLLED TRIAL)
PHASE II AIM 2: Malignant diagnosis of breast, lung, or colorectal cancer at any stage
PHASE II AIM 2: Receiving any type of cancer treatment
PHASE II AIM 2: Life expectancy of at least six months
PHASE II AIM 2: Current medical oncology outpatient status (participation will be suspended during hospitalization)
PHASE II AIM 2: Fluent in English
PHASE II AIM 2: Internet access at home

Reasons someone may not be able to joinExclusion criteria

PHASE I AIM 1 (STAKEHOLDER INPUT) EXCLUSION
PHASE I AIM 1: Clinical evidence of cognitive or psychological impairment
PHASE I AIM 1: Prisoners and pregnant women
PHASE I AIM 3.1 (EVALUATION STUDY) EXCLUSION
PHASE I AIM 3.1: Clinical evidence of cognitive or psychological impairment
PHASE I AIM 3.1: Prisoners and pregnant women
PHASE I AIM 3.2 (PILOT STUDY) EXCLUSION
PHASE I AIM 3.2: Clinical evidence of cognitive or psychological impairment
PHASE I AIM 3.2: Prisoners and pregnant women
PHASE I AIM 3.2: Currently participating in other psychosocial studies
PHASE II AIM 2 (RANDOMIZED CONTROLLED TRIAL) EXCLUSION
PHASE II AIM 2: Clinical evidence of cognitive or psychological impairment
PHASE II AIM 2: Prisoners and pregnant women
PHASE II AIM 2: Currently participating in other psychosocial studies

Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.

Study sites

U.S. locations

City of Hope Medical CenterDuarte, California

Source and freshness
Processed from ClinicalTrials.gov. Last public update: Jun 27, 2024. Always confirm current availability with the study team.

View original record ↗